期刊文献+

细胞黏附分子SLeX和CD24在喉鳞状细胞癌组织中的表达

Expressions of SLeX and CD24 in laryngeal squamous cell carcinoma tissues
下载PDF
导出
摘要 目的:探讨细胞黏附分子唾液酸化Lewis-X抗原(SLeX)和CD24在喉鳞状细胞癌组织中的表达,阐明其在喉鳞状细胞癌发生发展中的作用。方法:采用免疫组织化学方法分别检测42例喉鳞状细胞癌患者的42个原发灶、24个相应癌旁组织及20例睡眠呼吸暂停低通气综合征(OSAHS)手术患者的咽部正常黏膜组织中SLeX和CD24的表达情况。结果:喉癌组织、癌旁组织及对照正常黏膜组织中SLeX阳性表达率分别为71.4%、37.5%和30.0%;强阳性表达率分别为50.0%、8.3%和5.0%。CD24的阳性表达率分别为64.3%、33.3%和25.0%;强阳性表达率分别为35.7%、4.2%和0.0%。3组间两两比较,喉癌组织与癌旁组织、正常黏膜组织阳性表达率差异均有统计学意义(P<0.01);癌旁组织与正常黏膜组织阳性表达率差异无统计学意义(P>0.05)。SLeX、CD24强阳性表达与颈部淋巴结转移情况、临床分期及组织病理学分级相关(P<0.05)。SleX和CD24在喉癌组织中的阳性率呈显著正相关关系(r=0.695,P<0.05)。结论:SLeX及CD24蛋白表达与喉鳞状细胞癌的发生发展密切相关,其检测对喉癌的生物治疗和预测预后具有一定的临床意义。 Objective To discuss the expressions of SLeX and CD24 in laryngeal squamaous cell carcinoma(LSCC) tissues and clarify their roles in the occurrence and development in of LSCC.Methods The expressions of SLeX and CD24 in 42 cases of LSCC tissues,24 cases of adjacent tissues,and 20 cases of normal mucosa tissues were detected by immunohistochemical method.Results The positive expression rates of SLeX in laryngeal cancer tissues group,adjacent tissues group and normal tissues group were 71.4%,37.5%,and 30.0%,respectively.The positive expression rates of CD24 in laryngeal cancer tissues group,adjacent tissues group and normal tissues group were 64.3%,33.3%,and 25.0%,respectively.The strong positive expression rates of SLeX in laryngeal cancer tissues group,adjacent tissues group and normal tissues group were 50.0%,8.3%,and 5.0%,respectively.The strong positive expression rates of CD24 in laryngeal cancer tissues group,adjacent tissues group and normal tissues group were 35.7%,4.2%,and 0.0%,respectively.The positive expression rates of SLeX and CD24 had significant differences among laryngeal cancer tissues,adjacent tissues and normal tissues(P〈0.01).There was no significant difference between adjacent tissues and normal tissues(P〉0.05).The strong positive expressions of SLeX and CD24 had significant correlation with the metastases of the cervical lymph nodes,the clinic stages and histopathological classification.The expression level of SLeX had positive correlation with CD24 in LSCC tissue(r=0.695,P〈0.05).Conclusion The expressions of SLeX and CD24 are related to the occurrence and development of LSCC.The detection of the expressions of SLeX and CD24 has clinical significance on biotherapy and prognosis of LSCC.
出处 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2011年第2期304-307,F0003,共5页 Journal of Jilin University:Medicine Edition
基金 吉林省科技厅科技发展计划项目资助课题(200705275)
关键词 细胞黏附分子 SLEX CD24 喉肿瘤 肿瘤转移 cell adhesion molecules; SLeX; CD24; laryngeal neoplasms; neoplasm metastasis;
  • 相关文献

参考文献12

  • 1Christofori G. Changing neighbours, changing behaviour: cell adhesion molecule-mediated signalling during tumour progression[J]. EMBOJ, 2003, 22(10):2318-2323.
  • 2Hood JD, Cheresh DA. Role of integrins in cell invasion and migration[J]. Nat RevCancer, 2002, 2(2): 91-100.
  • 3Akamine S, Nakagoe T, Sawai T, et al. Differences in prognosis of colorectal cancer patients based on the expression of sialyl Lewisa, sialyl Lewisx and sialyl Tn antigens in serum and tumor tissue[J]. Anticancer Res, 2004, 24(4)-2541-2546.
  • 4Gouge-Ibert V, Pierry C, fluorinated C-mannopeptides P selectin inhibition E J 20(6): 1957-1960. Poulain F, et al. Synthesis of as sialyl Lewisx mimics for Eand Bioorg Med Chem Lett, 2010,.
  • 5Kobayashi M, Morita T. Significant expression patterns of lewis X-related antigens as a prognostic predictor of low stage renal cell carcinomas[J]. Anticancer Res, 2010, 30(2) : 593-599.
  • 6Luo Y, Barbault F, Gourmala C, et al. Cellular interaction through LewisX cluster: theoretical studies[J]. J Mol Model, 2008, 14(10): 901-910.
  • 7刘剑勇,覃宇周,吴飞翔,张力图,李挺,杨南武.胃癌患者手术前后血浆可溶性P-选择素的检测及意义[J].中华消化杂志,2001,21(3):185-186. 被引量:1
  • 8隋军,任艳鑫,李晓江,宋鑫,马静,高伟.鼻咽癌患者中CD4^+CD25^+T细胞与CCR4的相关性[J].西安交通大学学报(医学版),2009,30(6):746-750. 被引量:7
  • 9Winkler A, Zigeuner R, Rehak P, et al. CD24 expression in urothelial carcinoma of the upper urinary tract correlates with tumour progression [J]. Virchows Arch, 2007, 450(1): 59 64.
  • 10Karahan N, Guney M, Oral B, et al. CD24 expression is a poor prognostic marker in endometrial carcinoma [J]. Eur J GynaecolOncol, 2006, 27(5): 500-504.

二级参考文献18

  • 1PRADO-GARCIA H, AVILA-MORENO F, LOPEZ-GONZALEZ JS. Cytotoxic T lymphocytes in cancer and autoimmunity [J]. Rev Invest Clin, 2004, 56(5):629-639.
  • 2BRIVIO F, FUMAGALLI L, PAROLINi D, et al. T-helper/ T-regulator lymphocyte ratio as a new immunobiological index to quantify the anticancer immune status in cancer patients [J]. In Vivo, 2008, 22(5):647-650.
  • 3LIYANAGE UK, MOORE TT, JOO HG, et al. Prevalence of regulatory T ceils is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma [J]. J Immunol, 2002, 169(5):2756-2761.
  • 4ORMANDY LA, HILLEMANN T, WEDEMEYER H, et al. Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma [J]. Cancer Res, 2005, 65(6) :2457-2464.
  • 5WOO EY, CHU CS, GOLETZ TJ, et al. Regulatory CD4(+) CD25(+) T cells in tumors from patients with early-stage nonsmall cell lung cancer and late-stage ovarian cancer [J]. Cancer Res, 2001, 61(12):4766-4772.
  • 6YANG ZZ, NOVAK A J, STENSON MJ, et al. Intratumoral CD4^+CD25^+ regulatory T-cell-mediated suppression of infiltrating CD4^+ T cells in B-cell non-Hodgkin lymphoma [J]. Blood, 2006, 107(9) :3639-3646.
  • 7VIGUIER M, LEMA TRE F, VEROLA O, et al. Foxp3 expressing CD4^+ CD25 (high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells [J]. J Immunol, 2004, 15; 173 (2) : 1444-1453.
  • 8LAU KM, CHENG SH, LO KW, et al. Increase in circulating Foxp3^+ CD4^+ CD25 (high) regulatory T cells in nasopharyngeal carcinoma patients [J]. Br J Cancer, 2007, 96(4):617-622.
  • 9GIATROMANOLAKI A, BATES GJ, KOUKOURAKIS MI, et al. The presence of tumor-infiltrating FOXP3^+ lymphocytes correlates with intratumoral angiogenesis in endometrial cancer [J]. Gynecol Oncol, 2008, 110(2) :216-221.
  • 10KERSHAW MH, WANG G, WESTWOOD JA, et al. Redirecting migration of T cells to chemokine secreted from tumors by genetic modification with CXCR2 [J]. Hum Gene Ther, 2002, 13(16): 1971-1980.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部